We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Weekly paclitaxel combined with pegylated liposomal doxorubicin (CaelyxTM) given every 4 weeks: dose-finding and pharmacokinetic study in patients with advanced solid tumors.
- Authors
Briasoulis, E; Pentheroudakis, G; Karavasilis, V; Tzamakou, E; Rammou, D; Pavlidis, N
- Abstract
We aimed to define the maximum tolerated dose (MTD) and characterize the toxicity of the combination of pegylated liposomal doxorubicin (PLD; Caelyx trade mark ) and weekly paclitaxel (wPTX), and to investigate pharmacokinetics of PLD in this combination.
- Publication
Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Vol 15, Issue 10, p1566
- ISSN
0923-7534
- Publication type
Journal Article
- DOI
10.1093/annonc/mdh404